Oura as Women's Health Data Layer

This turns Oura from a gadget seller into shared health infrastructure for women’s care. The ring is no longer just showing sleep and temperature trends inside Oura’s app. It is being plugged into fertility, pregnancy, and menopause programs where clinicians and care navigators can use continuous biometrics alongside labs, symptom reports, and treatment plans, which makes Oura more valuable every time a care platform adopts it.1 2 3 4 5 6

• The partner set covers multiple high value moments in women’s health. Maven uses Oura across fertility to menopause, including the first direct use of Oura’s FDA listed ovulation insights inside a fertility care workflow. Progyny uses Oura from preconception through menopause. Evernow and Midi extend the ring into menopause care.2 3 4 5 6
• These integrations also create a B2B2C distribution channel, not just a software connection. Employer and health benefit platforms like Maven, Midi, and Progyny can bundle rings into care programs, and this channel already drives about 23% of new Oura ring sales. That means clinical partnerships feed both hardware volume and subscription adoption.1 3 6
• The closest comparison is not Apple Watch hardware, but benefits platforms like Maven and Progyny that own the care relationship. Maven covered 17 million people globally and was on track for $268M ARR in 2024, while Progyny was over $1.1B in trailing revenue. Sitting inside those workflows lets Oura become the biometric input layer those platforms do not natively own.2 3 7 8

The next step is for Oura to become the default wearable record for women’s health, similar to how lab companies became the default bloodwork layer. If more care platforms build around Oura data, the company gains leverage with employers, clinics, and insurers, and its moat shifts from ring design toward embedded clinical workflow and longitudinal health data.1 2 3 4 5 6